Global Transcatheter Embolization And Occlusion Devices Market to grow at a CAGR of 9.14% by 2030, Evaluates DelveInsight

According to DelveInsight's analysis, The transcatheter embolization and occlusion devices market is witnessing substantial growth, driven by the rising prevalence of chronic conditions such as cardiovascular diseases-including heart attack, atrial fibrillation, and coronary artery disease-as well as respiratory disorders like asthma and chronic obstructive pulmonary disease (COPD). Additionally, increasing product development initiatives by leading market players and other contributing factors are expected to propel market expansion during the 2024-2030 forecast period.

DelveInsight's "Transcatheter Embolization And Occlusion Devices Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transcatheter Embolization And Occlusion Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Transcatheter Embolization And Occlusion Devices market, get a snapshot of the report Transcatheter Embolization And Occlusion Devices Market Trends
https://www.delveinsight.com/sample-request/transcatheter-embolization-and-occlusion-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Transcatheter Embolization And Occlusion Devices Overview
Transcatheter embolization and occlusion devices are minimally invasive medical tools used to block or reduce blood flow in targeted blood vessels. Delivered via a catheter, they help treat conditions like aneurysms, tumors, arteriovenous malformations, and uncontrolled bleeding by inserting materials such as coils, plugs, or particles to seal the vessel and prevent abnormal circulation.

DelveInsight Analysis: The transcatheter embolization and occlusion devices market, valued at USD 3.71 billion in 2023, is projected to grow at a CAGR of 9.14% from 2024 to 2030, reaching approximately USD 6.25 billion by 2030.

Transcatheter Embolization And Occlusion Devices Market Insights
Geographically, North America is anticipated to lead the Transcatheter Embolization and Occlusion Devices market in 2023 and maintain its dominance through 2024-2030. This growth is driven by a substantial patient base in the US affected by respiratory disorders like COPD and cancer, along with associated risk factors. Additionally, the adoption of advanced medical technologies supported by strong regulatory frameworks in the region is expected to further propel the market during the forecast period.

To read more about the latest highlights related to Transcatheter Embolization And Occlusion Devices, get a snapshot of the key highlights entailed in the Transcatheter Embolization And Occlusion Devices
https://www.delveinsight.com/report-store/transcatheter-embolization-and-occlusion-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Transcatheter Embolization And Occlusion Devices Market Report
• In September 2024, Jupiter Endovascular, Inc. treated its first two patients in the SPIRARE I study (NCT06571760), evaluating the Vertex Pulmonary Embolectomy System with Endoportal ControlTM technology for Acute Pulmonary Embolism (PE). The initial cases took place at St. John Paul II Hospital in Krakow, Poland, affiliated with Jagiellonian University.
• In April 2021, Medtronic plc announced that it received approval from the United States Food and Drug Administration (FDA) for the pipeline Flex Embolization Device with Shield Technology. Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device which demonstrates the reduction in material thrombogenicity, a reduction in the tendency of the surface treatment material to create clots.
• In March 2021, The US Food and Drug Administration (FDA) cleared Boston Scientific's TheraSphere Y-90 Glass Microspheres, an interventional radiology therapy developed for the transcatheter treatment of patients with hepatocellular carcinoma (HCC).
• Thus, owing to such developments in the market, rapid growth will be observed in the Transcatheter Embolization And Occlusion Devices market during the forecast period

Key Players in the Transcatheter Embolization And Occlusion Devices Market
Some of the key market players operating in the Transcatheter Embolization And Occlusion Devices market include- Boston Scientific Corporation, Medtronic PLC, Penumbra, Inc, Cook Medical Inc, Edwards Lifesciences Corporation, Merit Medical Systems, Inc, Johnson & Johnson Services, Inc, Lepu Medical Technology(Beijing)Co., Ltd, Kaneka Medix Corporation, Stryker Corporation, phenox GmbH, Braile Biomédica, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc, and others.

Which MedTech key players in the Transcatheter Embolization And Occlusion Devices market are set to emerge as the trendsetter explore @ Key Transcatheter Embolization And Occlusion Devices Companies
https://www.delveinsight.com/sample-request/transcatheter-embolization-and-occlusion-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Transcatheter Embolization And Occlusion Devices Market Landscape
The Transcatheter Embolization and Occlusion Devices market is expected to grow further with new product approvals. For example, in June 2021, Achieva Medical, a subsidiary of Peijia Medical, received approval from the National Medical Products Administration (NMPA) to commercialize its newly developed detachable coil, Jasper SS. Similarly, in April 2022, Boston Scientific Corporation obtained FDA 510(k) clearance for its 'Embold' fibered detachable coil, designed to block or slow blood flow in the peripheral vasculature.

These developments are anticipated to boost demand for the coil segment, significantly contributing to the overall market growth from 2024 to 2030.

Scope of the Transcatheter Embolization And Occlusion Devices Market Report
• Coverage: Global
• Study Period: 2021-2030
• Transcatheter Embolization And Occlusion Devices Market Segmentation By Product Type: Coiled [Pushable Coils, Detachable Coils], Non-Coiled [Flow Diverting Devices, Embolization Particles, Liquid Embolic, Others
• Transcatheter Embolization And Occlusion Devices Market Segmentation By Application Type: Peripheral Vascular Disease, Oncology, Neurology, Urology, Others
• Transcatheter Embolization And Occlusion Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Transcatheter Embolization And Occlusion Devices Market Segmentation By End Users: Hospitals & Clinics, Ambulatory Surgical Centers, and others
• Key Transcatheter Embolization And Occlusion Devices Companies: Boston Scientific Corporation, Medtronic PLC, Penumbra, Inc, Cook Medical Inc, Edwards Lifesciences Corporation, Merit Medical Systems, Inc, Johnson & Johnson Services, Inc, Lepu Medical Technology(Beijing)Co., Ltd, Kaneka Medix Corporation, Stryker Corporation, phenox GmbH, Braile Biomédica, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.